Femasys Announces FDA Approval Of Modular Pma Submission Approach For FemBloc
FEMY•FDA approves modular PMA submission approach for FemBloc
Aug. 19 (Reuters) - Femasys Inc FEMY.O:
- Femasys announces FDA approval of modular PMA submission approach for FemBloc®.
- Femasys - FDA approves modular PMA pathway for FemBloc in the United States.
- Femasys - FemBloc approved for marketing in Europe and select international markets.
